Fenofibrate might scale back coronary heart illness threat in some sufferers with sort 2 diabetes
A brand new examine exhibits that the drug fenofibrate may scale back the chance of cardiovascular occasions in sufferers with kind 2 diabetes who've excessive ranges of triglycerides and low ranges of "good" ldl cholesterol, regardless of being handled with statins. The examine, funded by the Nationwide Coronary heart, Lung, and Blood Institute (NHLBI), seems within the December 28 subject of JAMA Cardiology . Fenofibrate is primarily used to assist scale back elevated ranges of triglycerides, or fats, within the blood. However the researchers wished to know if the drug, when mixed with statin therapy, might additionally scale back the chance of coronary heart illness in individuals with kind 2 diabetes. Individuals with kind 2 diabetes are at excessive danger of cardiovascular-related occasions, reminiscent of coronary heart assaults, stroke, and even dying, actually because their ranges of triglycerides are so excessive, and their high-density lipoprotein (HDL) le...